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Abstract 
 
Studies from several low- and middle-income countries have shown that antenatal 
depression may be a risk factor for poor neonatal outcomes. However, those studies 
conducted in sub-Saharan Africa have not consistently demonstrated this association. 
We set out to investigate whether antenatal depression is associated with shorter 
duration of pregnancy and reduced newborn size in rural Malawi. Pregnant women 
recruited from four antenatal clinics to the ILINS-DYAD-M randomised controlled trial 
of nutrient supplementation were screened for antenatal depression in the second or 
third trimester using a locally validated version of the Self Reporting Questionnaire 
(SRQ). Outcomes were duration of pregnancy, birthweight, newborn length for age z-
score (LAZ), head circumference z-score, and mid-upper arm circumference (MUAC). 
Other potential confounding factors and predictors of birth outcome were measured and 
adjusted for in the analysis. 1391 women were enrolled to the trial. 1006/1391 (72.3%) 
of these women completed an SRQ and gave birth to a singleton infant whose weight 
was measured within 2 weeks of birth. 143/1006 (14.2%) scored SRQ≥8 indicating 
likely depression. Antenatal depression was not associated with birth weight, duration 
of pregnancy, newborn LAZ or head-circumference Z-score. There was an inverse 
association with newborn MUAC (adjusted mean difference -0.2cm (95% CI -0.4 to 0, 
p=0.021)) the significance of which is unclear. The study was conducted within a RCT 
of nutritional supplementation and there was a high proportion of missing data in some 
enrolment sites; this may have affected the validity of our findings. 
 
  
Introduction 
 
Preterm birth (PTB) and intrauterine growth retardation (IUGR) are both common in 
low- and middle-income countries (LMIC). Both prematurity and IUGR are associated 
with neonatal death, childhood morbidity, poor postnatal growth and delayed 
psychomotor development (Howson et al., 2013). Depression occurring in the antenatal 
period is an important health problem globally including in LMIC. A systematic review 
found a weighted mean prevalence of antenatal common mental disorders in low and 
lower-middle income countries of 15.6% (Fisher et al., 2012). 
 
Antenatal depression has been shown to be a predictor of poor neonatal outcomes 
although there is considerable heterogeneity between studies.  A meta-analysis of 29 
studies showed that antenatal depression is associated with both PTB and IUGR, with 
associations more likely to be found in studies from LMIC, socio-economically 
deprived populations in the US, and in studies that used categorical vs continuous 
measures of depressive symptoms (Grote et al., 2010). Antenatal depression may affect 
foetal growth through poor maternal self-care, nutrition and healthcare-seeking, or 
through a direct effect of stress-related physiological changes on the intrauterine 
environment (Stewart, 2007; Glover, 2014) 
 
In studies from LMIC outside Africa, antenatal depression (or a high level of depressive 
and anxious symptoms) was found to be a risk factor for IUGR or low birth weight 
(LBW) in prospective studies from Pakistan (Rahman et al., 2004), Brazil (Rondo et 
al., 2003), India (Patel & Prince, 2006), Bangladesh (Nasreen et al., 2010) and Vietnam 
(Niemi et al., 2013); and a risk factor for PTB in Brazil (Rondo et al., 2003) and 
Vietnam (Niemi et al., 2013). Results from sub-Saharan African studies have been 
mixed, with associations found only in some studies and for varying neonatal outcomes.  
Antenatal depression was inversely associated with infant birth weight in a study 
conducted in rural Ethiopia (Wado et al.,  2014), and with lower newborn head 
circumference in a South African study (Brittain et al., 2015) . In a large prospective 
cohort study in Ghana, there was a marginal association with PTB but no association 
with low birth weight (Weobong et al., 2014). In a prospective case-control study of 
HIV+ pregnant women in Zambia, Collin et al. (2006) found an association between 
high levels of depressive and anxious symptoms and lower birth length (but not birth 
weight or PTB). In a prospective cohort study in Ethiopia, Hanlon et al. (2009) found 
no association between high levels of depressive and anxious symptoms antenatally and 
either birth weight or gestational age at delivery. A study restricted to women with low 
risk pregnancies in Ghana and Cote D’Ivoire also showed no significant associations 
(Bindt et al., 2013).  
 
Malawi is a low-income country in sub-Saharan Africa. The estimated rate of PTB in 
Malawi is 18.1% (Blencowe et al., 2012) and 37.4% of children under 5 years are 
stunted (National Statistical Office [Malawi] & ICF, 2017). The prevalence of antenatal 
major depressive episode has been estimated as 10.7% (Stewart et al., 2014a). No 
previous studies have investigated whether antenatal depression is associated with poor 
neonatal outcomes in Malawi. 
 
In this prospective study, conducted as part of a randomised controlled trial of lipid-
based nutrient supplements (LNS) in rural Malawi, we set out to determine whether a 
high level of antenatal depressive symptoms was an independent predictor of shorter 
duration of pregnancy and reduced neonatal size after adjustment for likely 
confounders.  
 
Method 
 
The ILINS-DYAD-M trial was a randomised controlled trial designed to study the 
impact on child growth and development of providing a lipid-based nutrient supplement 
to women during the perinatal period. The trial methodology is described in full 
elsewhere (Ashorn et al. 2015). The trial is registered at the clinical trial registry at the 
National Institute of Health (USA) under identifier NCT01239693 
(https://clinicaltrials.gov/ct2/show/NCT01239693). 
The trial was conducted in Mangochi District, a predominantly rural area situated at the 
southern end of Lake Malawi. Key economic activities in the district are subsistence 
farming, fishing and small-scale business. The two most widely spoken languages are 
Chichewa and Chiyao. Participants were recruited from the population of women 
attending antenatal clinics in the government-run Mangochi District Hospital, a part-
private hospital (Malindi) and two government-run health centres (Lungwena and 
Namwera). Consenting participants were randomly allocated to one of three study arms; 
the intervention arm (lipid-based nutrient supplements, LNS) or one of two comparator 
arms (iron–folic acid (IFA) and multiple micronutrients (MMN)). Supplements were 
delivered fortnightly to each participant. The study participants attended antenatal and 
under-5 clinics according to the same schedule as all other Malawian pregnant women 
and infants and received all normal preventive services provided by the national health 
system. Participants were refunded for any medical costs incurred during the study 
period. 
Inclusion criteria were: pregnancy of no more than 20 completed gestation weeks 
(confirmed by ultrasound), being resident in the defined catchment area and available 
during the study period, and giving informed consent (signed or thumb print). Exclusion 
criteria were: age less than 15 years, a chronic health condition requiring regular 
medical attention, asthma (formally diagnosed and on treatment), a severe illness 
requiring referral to hospital or emergency medical care, peanut allergy, history of any 
serious allergic reaction, significant pregnancy complications at enrollment visit, 
previous recruitment to the trial (during a previous pregnancy), or current enrollment 
in another clinical trial. 
Measurement of antenatal depression 
Maternal antenatal depressive symptoms were measured in the second or third trimester 
using the Self Reporting Questionnaire (SRQ). The SRQ was designed by the World 
Health Organisation as a screen for common mental disorders that could be used 
internationally and particularly in LMIC (WHO, 1994). It consists of 20 questions with 
yes/no answers exploring symptoms of depression, anxiety, and somatic manifestations 
of distress experienced over the previous 4 weeks. Scores are obtained by totaling the 
number of yes answers, with higher scores indicating higher number of depressive 
symptoms (possible score range 0-20). The SRQ was validated in a local sample of 
women attending an antenatal clinic at one of the study sites (Stewart et al., 2013). At 
a cut-off score of SRQ ≥8 (a cut-off commonly chosen in previous studies (Harpham et 
al., 2003)), the SRQ Chichewa version had sensitivity 50.4%, specificity 88.4%, and 
positive predictive value (PPV) of 41.2% for detection of Diagnostic and Statistical 
Manual of Mental Disorders 4th edition  (DSM-IV) major depressive episode. The test 
characteristics of the Chiyao translation of the SRQ were similar (unpublished data) 
 Data collectors were trained in the administration of the SRQ by a clinical psychologist 
fluent in English, Chichewa, and Chiyao (EU) and given written instructions for later 
reference. At interview, any participant answering “yes” to the item about suicidal 
thoughts was asked further questions regarding suicidal ideation. Any participant 
reporting active or persistent suicidal ideas was referred to local mental health care 
services (nurse-led outpatient clinics). During the study, no participants fulfilled this 
criterion.  
Other variables 
We measured the following maternal variables at, or shortly following, enrolment: age, 
number of years of education completed, number of previous pregnancies, household 
ownership of a set of assets (combined into an index with a mean of zero and standard 
deviation of one, using principal components analysis (Vyas & Kumaranayake 2006)), 
Household Food Insecurity Access Scale (HFIAS, a 9-item measure with higher scores 
indicating greater food insecurity) and season of enrolment (divided into quarters: Jan-
Mar, Apr-Jun, Jul-Sept, Oct-Dec). The Multidimensional Scale of Perceived Social 
Support (MSPSS) was administered at the same time as the SRQ. The MSPSS is a 
measure of the perception of the adequacy of support from others that was translated 
and locally validated; higher scores indicate greater perceived support (Stewart et al., 
2014b). 
 
At enrolment, trained anthropometrists measured the participants’ weight, height, and 
MUAC. All measurements were done in triplicate, using scales with a reading 
increment of 50g (SECA 874 flat scale; Seca GmbH & Co.), stadiometers with a 
reading increment of 1 mm (Harpenden stadiometer; Holtain Limited), and plastic tapes 
with a reading increment of 1 mm (Shorrtape; Weigh and Measure LLC). 
 
To estimate the duration of gestation, research nurses measured fetal abdominal 
circumference, biparietal diameter and femur length (all taken in duplicate, measured 
in millimetres) with ultrasound imagers with inbuilt Hadlock tables (EDAN DUS 3 
Digital Ultrasonic Diagnostic Imaging System; EDAN Instruments Inc.). They 
measured participants’ malaria parasitemia in peripheral blood using rapid tests 
(Clearview Malaria Combo; British Biocell International Ltd.) and hemoglobin 
concentration using on-site cuvette readers (HemoCue AB; Angelholm). After 
providing pretest counselling, nurses employed in the health facility tested for HIV 
infection (whole-blood antibody rapid test (Alere Determine HIV-1/2; Alere Medical 
Co, Ltd.) in all participants except those who opted out or were already known to be 
HIV infected,. If the result was positive, the test was checked using another rapid test 
(Uni-Gold HIV; Trinity Biotech plc). 
 
Outcome measures 
All participating women were provided with mobile phones so that they could promptly 
inform the study team about deliveries. On notification of a delivery, a member of the 
study team visited the woman, interviewed her about delivery time and measured the 
infant’s birth weight with an electronic infant weighing scale with a reading increment 
of 20 g (SECA 381 baby scale; Seca GmbH & Co.). One to two weeks postnatally, 
mother and infant were brought to the study clinic where study anthropometrists 
measured (in triplicate) the infant’s length (recorded to the nearest 1 mm) with a length 
board (Harpenden Infantometer; Holtain Limited), weight with electronic scales as used 
at immediate postnatal visit, and head circumference and MUAC (recorded to the 
nearest 1 mm) with plastic tapes (Shorrtape; Weigh and Measure LLC). Further details 
of quality control are fully described elsewhere  (Ashorn et al. 2015). Data collectors 
made tracing home visits if a participant did not come for the scheduled visit within 14 
d of the appointment.  
The duration of pregnancy was calculated by adding the time interval between 
enrolment and delivery to the ultrasound-determined gestational age at enrolment. Birth 
weight was used directly if measured within 48 hours of delivery or back-calculated 
from data collected between 6 and 13 days after delivery by using the WHO z-scores. 
If birth weight was first measured between 2 and 5 days after delivery (when weight 
loss is typical), it was calculated as a percentage of the actual measured weight 
(Cheung, 2013). Age- and sex-standardized anthropometric indices (length-for-age, 
and head circumference z-scores) were calculated by using the WHO Child Growth 
Standards (Fall et al., 2009).  
 
 
Statistical analysis  
 
The mean of the first 2 readings of anthropometric measurements (that were done in 
triplicate) was used if those 2 readings did not differ by more than a prespecified 
tolerance limit. If the difference exceeded the limit, the third measurement was 
compared with measurements 1 and 2, and the mean was calculated from the pair of 
measurements with the smallest difference. When only one or 2 repeated measurements 
were done, the mean of those was used 
 
The characteristics of the sample included in the analysis vs those excluded because of 
missing data were compared using the t-test for continuous data, and Chi squared or 
Fishers exact test for categorical data. Prevalence of antenatal depression (SRQ ≥8) was 
calculated. Mean (SD) neonatal outcomes (gestational age at delivery, birth weight, 
LAZ, head circumference z-score and MUAC) in the 2 groups (maternal depressed vs 
not depressed) were compared in univariate (t-test) and multivariate (linear regression) 
analyses. Variables entered into the adjusted analyses were child sex; number of 
previous pregnancies; maternal MUAC and height; maternal HIV status, haemoglobin 
concentration and malaria test result at enrolment; gestational age at enrolment, marital 
status; season of enrolment (entered as 3 dummy variables); study site (entered as 3 
dummy variables); trial intervention group (entered as 2 dummy variables); and 
language (Chichewa vs Chiyao).  
 
We conducted an exploratory analysis to investigate whether associations between 
antenatal depression and birth/neonatal outcomes were moderated by other variables. 
Interaction terms were created for depression by child sex, maternal height, MUAC, 
malaria at enrolment, haemoglobin, years of education, site of enrolment, season of 
enrolment, trial intervention group, MSPSS score, food insecurity (HFIA) score, assets 
score, and number of previous pregnancies. These were added separately to the linear 
regression analysis for each of the outcomes. If the interaction term was significant 
(p<0.05) then we examined the association of antenatal depression with the outcome 
stratified by the moderator. 
 
 
  
Results 
 
Participant flow and sample characteristics 
Participant flow is shown in Figure 1. Between February 2011 and August 2012, 9304 
women were approached at the antenatal clinics of the four study sites. Of these, 4449 
were excluded and 3470 were not interested in participating. 1391/9304 (15.0%) were 
enrolled to the trial. The enrolled participants and those who refused or were not eligible 
were similar in mean age, number of completed school years, marital status, home 
building material, and ownership of phones in the household. See Ashorn et al. (2015).  
Out of 1391 enrolled, 1006 (72.3%) women completed the SRQ and gave birth to a 
singleton infant whose weight was measured within 2 weeks of birth. All analyses were 
restricted to this group. A comparison of those with and without data is shown in Table 
1. Compared to those included in the analysis (n=1006), those with missing data 
(n=385) were younger, were later in gestation at enrolment, had higher asset score, had 
had fewer previous pregnancies and were more likely to have a positive malaria test. 
They had higher antenatal SRQ scores, lower haemoglobin and were more likely to be 
enrolled in Q3/Q4 and from a site other than Malindi. 
 
For the 1006 participants the following neonatal outcomes were recorded: LAZ in 911 
(90.6%), MUAC in 919 (91.4%) and head circumference in 913 (90.8%).  
 
Prevalence of depression and infant outcomes 
143/1006 (14.2%) of participating women scored SRQ≥8 indicating likely antenatal 
depression. For the total sample, mean (SD) values for birth outcomes were birth weight 
2977 (441) g, gestational age 39.6 (1.9) weeks, neonatal LAZ -0.97 (1.10), head-
circumference Z-score -0.13(1.06), and MUAC 10.6 (0.9) cm. The incidence of low 
birth weight (<2500 g) was 12.3%, low newborn length (z-score <−2.0) was 15.1%, 
and preterm delivery (<37 weeks gestation at birth) was 6.6%. 
 
 
Associations between antenatal depression and birth outcomes  
Table 2 shows associations between antenatal depression and birth outcomes in 
adjusted analyses. Antenatal depression was not associated with birth weight, 
gestational age, neonatal LAZ or head-circumference Z-score, but was inversely 
associated with MUAC (mean difference -0.2cm (95%CI -0.4 to 0.0, p=0.021)). 
 
Exploratory analysis of factors that may moderate the associations between 
antenatal depression and birth/newborn outcomes. 
In exploratory analyses of moderation, for birth weight there were interactions between 
antenatal depression and number of previous pregnancies (dichotomised at median) 
(p=0.039), number of years of education (dichotomised at median) (p=0.017) and trial 
intervention group (LNS-vs-comparator arms dummy variable p=0.044). Table 3 shows 
associations between antenatal depression and birth weight in adjusted analyses 
stratified by these variables. For newborn LAZ, there were interactions between 
antenatal depression and season of enrolment (in quarters) (Q1-vs-Q2,3,4 dummy 
variable (p=0.021); Q3-vs-Q1,2,4 dummy variable (p=0.013)) and site of enrolment 
(Malindi-vs-other sites dummy variable, (p=0.037)). In Malindi, adjusted mean 
difference (95% CI) in newborn LAZ between infants born to mothers with antenatal 
depression vs those without depression was -0.48 (-0.97 to -0.09), p=0.016; in other 
sites, it was 0.075 (-0.162 to 0.313), p=0.535. 
 
Discussion 
 
In this prospective study, conducted in a predominantly rural area in a low-income 
country in sub-Saharan Africa, antenatal depression was not associated with duration 
of pregnancy, birthweight, newborn length or head circumference. This study adds to 
those studies from the sub-Saharan African literature that have not found antenatal 
depression to be a risk factor for prematurity or low birthweight. There was an isolated 
finding of an inverse association between antenatal depression and newborn MUAC, 
with a mean difference of 0.2cm, the significance of which is unclear. In addition, 
several limitations of the study may have affected the validity of our findings. 
 
Strengths of the study included the prospective design, the dating of gestational age at 
recruitment by USS, and quality-controlled infant anthropometry conducted by trained 
data collectors. We measured a range of potential confounders of any association 
between antenatal depression and birth outcomes and adjusted for these in multivariate 
analyses. 
 On the other hand, there were a number of limitations to the study. We conducted the 
study within a trial of nutritional supplementation that was not specifically designed to 
answer the study question, and no a priori sample size calculation was conducted. All 
the participants received some form of nutritional supplement (iron/folate, multi-
micronutrient tablets or a lipid-based nutritional supplement) which could all have had 
a beneficial effect on maternal health including reduced levels of antenatal depression 
and anxiety. Maternal dietary supplements could also have had a beneficial effect on 
foetal growth which may have swamped any impact of symptoms of depression and 
anxiety. It should be noted, however, that the LNS intervention was not effective at 
significantly improving neonatal size (Ashorn et al., 2015), or maternal depression at 6 
months postpartum (Stewart et al., 2016). The high refusal rate for inclusion in the trial 
and the missing SRQ and birth outcome measurements may have led to a biased sample 
not representative of the population as a whole. Of note, in exploratory analysis, we 
found that in the site with a high proportion of complete data (91.3%), depression was 
inversely associated with LAZ, whereas no such association was found in the remaining 
sites that had less complete data (68.3%). However, this was an exploratory analysis 
only and the sites also differed on a number of other variables.  
 
Although we used an adapted version of the SRQ that had been locally validated for 
use in the antenatal period (Stewart et al., 2013), the SRQ is only a screening tool and 
does not provide a formal diagnosis of depressive disorder. At the chosen cut-off, the 
SRQ had high specificity but low sensitivity so there will have been some 
misclassification of cases, although this non-differential misclassification is more likely 
to have led to type 2 rather than type 1 error. Screening tools such as the SRQ may be 
more likely to detect self-limiting distress states that may not have the same 
implications for foetal development as major depressive disorder. Of note, most 
previous studies investigating antenatal depression and birth outcomes in sub-Saharan 
Africa have also used screening tools rather than diagnostic interviews.   
 
We measured and adjusted for a wide range of potential confounders; however, the 
possibility of residual confounding remains. The heterogeneity in the results of studies 
investigating antenatal depression and birth outcomes in sub-Saharan Africa may be 
accounted for, in part, by differences in the completeness of adjustment for 
confounders. Bindt et al. (2013) argue that some studies did not adjust for the effect of 
physical morbidity during pregnancy that might be expected to confound the 
association between antenatal symptoms of depression and anxiety, and birth outcomes. 
To overcome this, they restricted their sample to women with low-risk pregnancies and 
found no association between antenatal depression and birth outcomes.  
 
In this study, we used a range of measures of birth size (i.e. weight, length, MUAC, 
head circumference) and only found a consistent association with MUAC. Other studies 
have also shown associations with only selected outcome measures, e.g. of a range of 
outcomes, Brittain et al. (2015) only found an association with head circumference. Our 
use of multiple outcome measures will have increased the risk of positive findings 
occurring by chance, but different anthropometric measures can reflect different 
nutritional states resulting from differing intrauterine nutritional deficits and their 
timings. 
 
Finally, a possible cause of heterogeneity in the results of studies of antenatal 
depression and birth outcomes in sub-Saharan Africa is that the study sites differed in 
the prevalence of other risk factors for poor birth outcomes. The effects of nutritional 
deficiencies, infectious disease (including HIV), and restricted access to reproductive 
health services may swamp any effect of antenatal depression and/or influence the 
functional impact that being depressed has on the ease of maintaining health and 
nutrition during pregnancy. Socio-cultural factors that influence reproductive and 
mental health may also differ between settings. In our exploratory analysis of 
moderating factors, we found that antenatal depression was associated with lower birth 
weight in women with three or more previous pregnancies and those with less than four 
years of education. These analyses were exploratory and we did not adjust the 
significance level for the multiple comparisons made, so it is possible that the findings 
occurred by chance. 
 
Conclusion 
In this study in rural Malawi, we did not find antenatal depression to be associated with 
duration of pregnancy, or measures of newborn size other than inversely with MUAC. 
Given its limitations, the study does not resolve the conflicting findings regarding the 
association between antenatal psychiatric morbidity and prematurity and/or low birth 
weight in sub-Saharan Africa. It has, however, highlighted the role that methodological 
differences and limitations (that are often encountered when conducting research in low 
resource settings) may have in explaining the heterogeneous findings. Given the high 
prevalence of both poor birth outcomes and perinatal mental health problems in Malawi 
and other sub-Saharan African countries, further community based cohort studies are 
warranted to further understanding of this important public health issue. 
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Figure 1 
 
 
  
Table 1. Characteristics of participants enrolled to the trial (n=1391) who completed 
the SRQ and gave birth to a singleton infant whose gestational age and birth weight 
were recorded (n=1006), versus those missing these data (n=385)  
 
Included 
n=1006 (72.3%) 
Missing 
n=385 (27.7%) 
P-value 1 
Maternal age (years) (Mean (SD)) 25.3 (6.1) 24.0 (6.3) <0.005 
Maternal education (completed years) (Mean (SD)) 4.1 (3.4) 3.8 (3.6) 0.130 
Household asset score (Mean (SD)) -0.1 (1.7) 0.2 (2.0) 0.008 
Gestational age at enrolment (weeks) (Mean (SD)) 168 (2.2) 17.0 (2.0) 0.043 
Number of previous pregnancies (Mean (SD)) 2.2 (1.7) 1.8 (1.8) <0.005 
Height, cm (Mean (SD)) 156.2 (5.7) 155.7 (5.5) 0.141 
Weight, kg (Mean (SD)) 54.0 (7.8) 54.4 (8.5) 0.354 
MUAC, cm (Mean (SD)) 26.3 (2.6) 26.4 (2.8) 0.666 
BMI, kg/m2 (Mean (SD)) 22.1 (2.8) 22.4 (2.9) 0.088 
Blood haemoglobin concentration, g/L (Mean (SD)) 112.5 (15.9) 108.9 (17.1) <0.005 
MSPSS score (Mean (SD)) 37.1 (8.5) 37.1 (8.2) 0.979 
Positive HIV test, %  13.9 13.3 0.802 
Positive malaria test (RDT) % 21.6 27.3 0.024 
SRQ completed in Chichewa % 55.9 58.4 0.497 
Trial Arm % 
IFA 33.8 31.9 
0.789 MMN  33.1 34.5 
LNS  33.1 33.5 
Season of enrolment % 
Jan-Mar 24.9 19.5 
<0.005 
Apr-June 30.2 21.8 
July-Sept 27.0 32.5 
Oct-Dec 17.9 26.2 
Site of enrolment % 
Lungwena 35.7 40.5 
<0.005 Malindi 22.0 5.5 
Namwera 15.9 15.8 
Mangochi 26.4 38.2 
1 comparison used the t-test for continuous data, and Chi squared or Fishers exact test for 
categorical data.  
IFA, Iron-folate; MMN, multiple micronutrients; LNS, lipid-based nutrient supplements; SRQ, 
Self Reporting Questionnaire; MSPSS, Multi-dimensional Scale of Perceived Social Support. 
 
  
Table 2. Adjusted associations between antenatal depression and birth/newborn 
outcomes 
Outcome variable 
(no. of women without depression, 
no. of women with depression) 
Women 
without 
depression 
Women with 
depression 
Adjusted group comparisona 
 
Mean (SD) Mean (SD) Diff. in means  
(95% CI) 
P-
value 
Birth weight, g 
(n=863,143) 
2990 (440)  2920 (450)  -40 (-120 to 30) 0.259 
Duration of pregnancy, weeks 
(n=863,143) 
39.6 (1.9)  
 
39.4 (1.9) 0.2 (-0.2 to 0.5) 0.335 
Length for age z-score 
(n=783,128) 
-0.96 (1.10) 
 
-1.04 (1.09)  -0.09 (-0.29 to 0.12) 0.416 
Head circumference z-score 
(n=786, 127) 
-0.13 (1.06) 
 
-0.13 (1.07)  0.03 (-0.18 to 0.23) 0.777 
Mid upper arm circumference, cm 
(n=790,129) 
10.6 (0.9) 
 
10.4 (0.9)  -0.2 (-0.4 to 0.0) 0.021 
 
a - adjusted for child sex; number of previous pregnancies; maternal MUAC and height; maternal HIV 
status, haemoglobin concentration and malaria test result at enrolment; gestational age at enrolment; 
marital status; season of enrolment; enrolment site; trial intervention group; and language. 
 
 
  
Table 3. Associations between antenatal depression and infant birth weight stratified 
by number of previous pregnancies, number of years of education and trial 
intervention group. 
 
Stratified by: Strata 
(no. of women without depression, 
no. of women with depression) 
Mean birthweight (SD) Adjusted group comparisona 
Women without 
depression 
Women with 
depression 
Diff. in means  
(95% CI) 
P-
value 
Number of 
previous 
pregnancies 
0-2 previous pregnancies 
(n=508, 78) 
2940 (440) 2920 (480) 40 (-70 to 150) 0.490 
3 or more previous pregnancies 
(n=354, 65) 
3060 (420)  2920 (410)  -120 (-240 to -10) 0.035 
No. of years of 
education 
0-3 years of education 
(n=420, 58) 
3000 (410)  2840 (390) -140 (-260 to -30) 0.011 
4 or more years of education 
(n=439, 84) 
2980 (460) 2980 (490) 40 (-70 to 150) 0.446 
Trial 
intervention 
group 
Iron/Folate (IFA) 
(n=290, 50) 
2970(410) 2900 (470) -60 (-190 to 70) 0.389 
Multi-micronutrients (MMN) 
(n=284, 49) 
2960(460) 2970 (450) 40 (-100 to 180) 0.554 
Lipid-based Nutrient Supplements 
(LNS) (n=289, 44) 
3030(450) 2890 (430) -120 (-260 to 30) 0.109 
 
a – All analyses adjusted for child sex; maternal MUAC and height; maternal HIV status, haemoglobin 
concentration and malaria test result at enrolment; gestational age at enrolment; marital status; season 
of enrolment; enrolment site; and language.  
No. of previous pregnancies analysis also adjusted for number of years of education and trial 
intervention group; 
No. of years of education analysis also adjusted for number of previous pregnancies and trial 
intervention group; 
Trial arm analysis also adjusted for number of previous pregnancies and no. of years of education 
 
 
 
 
 
